Tamoxifen, another type of hormone therapy, may not cause as much bone loss in postmenopausal women and might even help maintain bone density. However, it has other side effects and risks. The choice between tamoxifen and aromatase inhibitors depends on various factors, including the patient’s menopausal status, risk of recurrence, and personal health profile.